Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells

Oncology Reports

Volumn 28, Issue 1, 2012, Pages 91-98

  Wang, Shiyong ^a   Zeng, Xue ^a   Liu, Yanping ^b   Liang, Chunyan ^a   Zhang, Hui ^a   Liu, Chang ^a   Du, Weili ^a   Zhang, Zhe ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Shenyang Weikang Hospital   (China)

Author keywords

Cell line; Genetic vectors; Human; Lentivirus; Programmed cell death 5 protein; Recombination, genetic; Tumor

Indexed keywords

GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; PLASMID DNA; PROTEIN PDCD5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA PURIFICATION; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; GENOMIC FRAGMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; ONCOGENE; PDCD5 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; CLONING, MOLECULAR; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LENTIVIRUS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSFECTION; TRANSITION TEMPERATURE; VIRAL LOAD; VIRUS ASSEMBLY;

EID: 84861553177     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1756     Document Type: Article

References (29)

1. Liu H, Wang Y, Zhang Y, et al: TFAR19, a novel apoptosis related gene cloned from human leukemia cell line TF21, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophy Res Commun 254: 203-210, 1999. (Pubitemid 29292042)
2. Zhang X, Wang X, Song X, et al: Clinical and prognostic significance of lost or decreased PDCD5 expression in human epithelial ovarian carcinomas. Oncol Rep 25: 353-358, 2011.
3. Chen C, Zhou H, Xu L, et al: Prognostic significance of down-regulated expression of programmed cell death 5 in chondrosarcoma. J Surg Oncol 102: 838-843, 2010.
4. Du YJ, Xiong L, Lou Y, Tan WL and Zheng SB: Reduced expression of programmed cell death 5 protein in tissue of human prostate cancer. Chin Med Sci J 24: 241-245, 2009.
5. Li H, Wang Q, Gao F, et al: Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Oncol Rep 20: 573-579, 2008.
6. Ruan GR, Chen SS, Ma X, et al: Abnormal expression of PDCD5 in the bone marrow cells of adult acute myeloid leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15: 462-465, 2007.
7. Yang YH, Zhao M, Li WM, Lu YY, Chen YY, Kang B and Lu YY: Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells. Apoptosis 11: 993-1001, 2006. (Pubitemid 43876829)
8. Ruan GR, Zhao HS, Chang Y, et al: Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo. Apoptosis 13: 641-648, 2008.
9. Yin A, Jiang Y, Zhang X, Zhao J and Luo H: Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo. Eur J Pharmacol 649: 120-126, 2010.
10. Liu J, Li X, Gui R, Jiang T and Wang E: Effect of human recombinant PDCD5 protein on cell apoptosis of multiple myeloma KM3 cells induced by dexamethasone and its mechanism.Zhong Nan Da Xue Xue Bao Yi Xue Ban 35: 725-731, 2010.
11. Shi L, Song Q, Zhang Y, et al: Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells. Biochem Biophys Res Commun 396: 224-230, 2010.
12. Chen C, Zhou H, Xu L, et al: Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis 15: 805-813, 2010.
13. Spinola M, Meyer P, Kammerer S, et al: Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. J Clin Oncol 24: 1672-1678, 2006. (Pubitemid 46622138)
14. Ma X, Ruan G, Wang Y, et al: Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5′ regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res 11: 8592-8599, 2005. (Pubitemid 43005905)
15. Nanba K, Toyooka S, Soh J, et al: The allelic distribution of a single nucleotide polymorphism in the PDCD5 gene locus of Japanese non-small cell lung cancer patients. Mol Med Rep 1: 667-671, 2008.
16. Chen Y, Sun R, Han W, Zhang Y, Song Q, Di C and Ma DL: Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis? FEBS Lett 509: 191-196, 2001. (Pubitemid 34015941)
17. Chen LN, Wang Y, Ma DL and Chen YY: Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression. Apoptosis 11: 101-111, 2006. (Pubitemid 43151648)
18. Yao H, Xu L, Feng Y, Liu D, Chen Y and Wang J: Structurefunction correlation of human programmed cell death 5 protein. Arch Biochem Biophys 486: 141-149, 2009.
19. Salvi M, Xu D, Chen Y, Cabrelle A, Sarno S and Pinna LA: Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells. Biochem Biophys Res Commun 387: 606-610, 2009.
20. Xu L, Chen Y, Song Q, Xu D, Wang Y and Ma D: PDCD5 interacts with Tip60 and functions as a cooperator in acetyltransferase activity and DNA damage-induced apoptosis. Neoplasia 11: 345-354, 2009.
21. Xu M, Cheng N, Gui L, et al: The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide. Gene 329: 39-49, 2004. (Pubitemid 38366493)
22. Menotti L, Nicoletti G, Gatta V, et al: Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. Proc Natl Acad Sci USA 106: 9039-9044, 2009.
23. Santhosh CV, Tamhane MC, Kamat RH, Patel VV and Mukhopadhyaya R: A lentiviral vector with novel multiple cloning sites: stable transgene expression in vitro and in vivo. Biochem Biophys Res Commun 371: 546-550, 2008.
24. Ravet E, Lulka H, Gross F, Casteilla L, Buscail L and Cordelier P: Using lentiviral vectors for efficient pancreatic cancer gene therapy. Cancer Gene Ther 17: 315-324, 2010.
25. Trobridge GD, Beard BC, Gooch C, et al: Efficient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors. Blood 111: 5537-5543, 2008.
26. Hunter MJ, Zhao H, Tuschong LM, Bauer TR Jr, Burkholder TH, Persons DA and Hickstein DD: Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters. Hum Gene Ther 22: 689-696, 2011.
27. Benabdellah K, Cobo M, Muñoz P, Toscano MG and Martin F: Development of an all-in-one lentiviral vector system based on the original TetR for the easy generation of Tet-ON cell lines. PLoS One 6: e23734, 2011.
28. Xie M, Niu JH, Chang Y, et al: A novel triple-regulated oncolytic adenovirus carrying PDCD5 gene exerts potent antitumor efficacy on common human leukemic cell lines. Apoptosis 14: 1086-1094, 2009.
29. Yu ST, Yang YB, Liang GP, et al: An optimized telomerasespecific lentivirus for optical imaging of tumors. Cancer Res 70: 2585-2594, 2010.